1 | rna | 5,144 |
2 | oligonucleotide | 251 |
3 | gag | 247 |
4 | ns5b | 67 |
5 | ribose | 55 |
6 | fluid-attenuated | 41 |
7 | o-antigen | 33 |
8 | coreceptor | 32 |
9 | sumo-2/3 | 32 |
10 | morpholino | 29 |
11 | rna-mediated | 28 |
12 | nucleoprotein | 27 |
13 | replicase | 27 |
14 | phosphorothioate | 25 |
15 | orf2 | 24 |
16 | ebv-dna | 21 |
17 | dnaemia | 20 |
18 | 2la | 19 |
19 | hsp16.3 | 18 |
20 | recombinase | 17 |
21 | rna1 | 13 |
22 | pp65 | 11 |
23 | retroactive | 11 |
24 | us1 | 11 |
25 | ngaan | 10 |
26 | dnak2 | 9 |
27 | gag/pol/nef | 9 |
28 | h-d | 8 |
29 | ljs09 | 8 |
30 | phase-sensitive | 8 |
31 | poly-adp-ribose | 8 |
32 | cs-us | 7 |
33 | ctca/cmr | 7 |
34 | exonucleolytic | 7 |
35 | infection/disease | 7 |
36 | p450-mediated | 7 |
37 | zk60 | 7 |
38 | 14-3-3-beta | 6 |
39 | a-positive | 6 |
40 | ar2 | 6 |
41 | cre-recombinase | 6 |
42 | dscam1 | 6 |
43 | endodomain | 6 |
44 | p24-antigen | 6 |
45 | p33 | 6 |
46 | us28 | 6 |
47 | 1/l | 5 |
48 | 1/l-induced | 5 |
49 | dnaaemia | 5 |
50 | eyyto | 5 |
51 | mir400 | 5 |
52 | orf1b | 5 |
53 | perv | 5 |
54 | rna/ml | 5 |
55 | thiohemiacetal | 5 |
56 | 111in-ldl | 4 |
57 | ab2o4 | 4 |
58 | antagomir | 4 |
59 | azetidine | 4 |
60 | e-mia | 4 |
61 | eif3c | 4 |
62 | envelop | 4 |
63 | im+lh | 4 |
64 | infection-enhanced | 4 |
65 | n-ntd | 4 |
66 | nf-at | 4 |
67 | nf449 | 4 |
68 | ny99 | 4 |
69 | pause-dependent | 4 |
70 | pp67 | 4 |
71 | rna- | 4 |
72 | rna-vl | 4 |
73 | ul23 | 4 |
74 | vflip | 4 |
75 | vpu | 4 |
76 | 00-1 | 3 |
77 | 253-kb | 3 |
78 | cain | 3 |
79 | clec2 | 3 |
80 | dermatol. | 3 |
81 | gag/pol | 3 |
82 | ghrd3/d3 | 3 |
83 | mixt | 3 |
84 | nl4-3 | 3 |
85 | o-glycopeptide | 3 |
86 | ori-rep | 3 |
87 | patient-matched | 3 |
88 | rna311 | 3 |
89 | sgfp | 3 |
90 | stockingette | 3 |
91 | trpm5-gfp | 3 |
92 | virion-associated | 3 |
93 | 36-kb | 2 |
94 | ad169 | 2 |
95 | c1212 | 2 |
96 | calcium-butyrate | 2 |
97 | chiasma | 2 |
98 | cover-slips | 2 |
99 | f-mediated | 2 |
100 | g-band | 2 |
101 | gdiα | 2 |
102 | genotype-iii | 2 |
103 | igg/igm | 2 |
104 | ikdc2000 | 2 |
105 | ires-mediated | 2 |
106 | ltr-luciferase | 2 |
107 | matrix-intermediate | 2 |
108 | n-ntds | 2 |
109 | nadh-linked | 2 |
110 | non-crystallographic | 2 |
111 | nsp2 | 2 |
112 | o-down | 2 |
113 | p24-like | 2 |
114 | pamps-induced | 2 |
115 | pcv2-derived | 2 |
116 | physical-biological | 2 |
117 | polypeptide-associated | 2 |
118 | promoter-regulated | 2 |
119 | pseudo-particles | 2 |
120 | pur46 | 2 |
121 | ra2cp248/404/1030deltash | 2 |
122 | ribonuclear | 2 |
123 | ribosyl | 2 |
124 | rna≥5 | 2 |
125 | rpl22 | 2 |
126 | short-tau | 2 |
127 | sipped | 2 |
128 | site-volume | 2 |
129 | sral2b2o7 | 2 |
130 | sub-genomic | 2 |
131 | thiazole-2-carbonitriles | 2 |
132 | tw-i | 2 |
133 | wt-11 | 2 |
134 | wt-7 | 2 |
135 | zd7155 | 2 |
136 | 'bacterial | 1 |
137 | 'biotic | 1 |
138 | 1,4-diaryl-5-methyl | 1 |
139 | 10.this | 1 |
140 | 12,028 | 1 |
141 | 127-iodine | 1 |
142 | 16s-dna | 1 |
143 | 2,3-diaminomaleonitrile | 1 |
144 | 2,5-dihydroazepines | 1 |
145 | 2-hydroxybenzophenones | 1 |
146 | 2-salicyloylfurans | 1 |
147 | 3-acyl-2-substituted | 1 |
148 | 3-monochloropropan-1,2-diol | 1 |
149 | 3-or | 1 |
150 | 3-tpye | 1 |
151 | 324.5 | 1 |
152 | 383.1 | 1 |
153 | 4-fluoroacetophenone | 1 |
154 | 4-tpye | 1 |
155 | 50-kb | 1 |
156 | 6-capi3k | 1 |
157 | a/pr8/34 | 1 |
158 | abstraction-induced | 1 |
159 | affective/activity | 1 |
160 | age-bsa | 1 |
161 | allele-containing | 1 |
162 | ampv-b | 1 |
163 | ancilla | 1 |
164 | anticomplement | 1 |
165 | aripiprazole.conclusions | 1 |
166 | autoantibody/gsk1995057 | 1 |
167 | aza-michael/aldol | 1 |
168 | bare-silica | 1 |
169 | bc-6/85 | 1 |
170 | benzazepines | 1 |
171 | biointrafix | 1 |
172 | calcium-calcium/calmodulin | 1 |
173 | canb2o6 | 1 |
174 | chemoprophylaxis.the | 1 |
175 | chordal/bileaflet | 1 |
176 | citalopram+bupropion | 1 |
177 | core-excitons | 1 |
178 | cotranslationally | 1 |
179 | cyclopentane-fused | 1 |
180 | cyclopentenones | 1 |
181 | cyclopropyl-4,5-dihydropyridazin-3-one | 1 |
182 | deazaflavin-dependent | 1 |
183 | diazatricyclic | 1 |
184 | disclosure.of | 1 |
185 | dna-cp | 1 |
186 | dual-anchor-against-an-anchor | 1 |
187 | echo-angio | 1 |
188 | electrostatic-fluid-thermal | 1 |
189 | eversion/ | 1 |
190 | factor-κb-inhibiting | 1 |
191 | factor3 | 1 |
192 | factor4 | 1 |
193 | fano | 1 |
194 | fd-mapped | 1 |
195 | feedforward-induced | 1 |
196 | finite-fields/finite-differences | 1 |
197 | fissioning | 1 |
198 | fluid-flow | 1 |
199 | gag-reactive | 1 |
200 | gamma0 | 1 |
201 | gd-specific | 1 |
202 | gi* | 1 |
203 | h360 | 1 |
204 | hemichromes | 1 |
205 | heterogroups | 1 |
206 | hexamethyl-propylene-amine-oxime | 1 |
207 | hiv-luciferase | 1 |
208 | hram-induced | 1 |
209 | hsp70-dnaj | 1 |
210 | hsp70-stimulated | 1 |
211 | hydrindanone | 1 |
212 | igm-ve | 1 |
213 | imp-3-hnrnpm | 1 |
214 | incubation-quantitative | 1 |
215 | infection-delivery | 1 |
216 | infection/reactivation | 1 |
217 | lanbo4 | 1 |
218 | liluf₄ | 1 |
219 | lipoprotein-mimetic | 1 |
220 | lithia | 1 |
221 | liver-transcription-factor | 1 |
222 | load=50 | 1 |
223 | lx4-type | 1 |
224 | medication.three | 1 |
225 | mirna-expression | 1 |
226 | mode-1 | 1 |
227 | mtdna-specific | 1 |
228 | mucin-related | 1 |
229 | mygdfx | 1 |
230 | ncp7-zn | 1 |
231 | nomarski | 1 |
232 | ns2b/ns3 | 1 |
233 | ofmost | 1 |
234 | oncotropism | 1 |
235 | p24gag | 1 |
236 | p4502d6 | 1 |
237 | pamps-mediated | 1 |
238 | paracentric | 1 |
239 | partonic | 1 |
240 | peptides/hsp | 1 |
241 | plasma/ms | 1 |
242 | pmma/nayf | 1 |
243 | pol-rt | 1 |
244 | polyuronides | 1 |
245 | premembrane | 1 |
246 | proserotonergic | 1 |
247 | prot-rt | 1 |
248 | pseudo-substrate | 1 |
249 | rabeprazole/tinidazole/minocycline/bismuth | 1 |
250 | retinitis-specific | 1 |
251 | retinits | 1 |
252 | rna,10,000 | 1 |
253 | rna-as | 1 |
254 | rna-expressing | 1 |
255 | rna-negative | 1 |
256 | rna≤600,000 | 1 |
257 | rna≥1,000 | 1 |
258 | rna≥100,000 | 1 |
259 | robot-applied | 1 |
260 | silvernanoparticles | 1 |
261 | single-side | 1 |
262 | speckle-type | 1 |
263 | subtype-a | 1 |
264 | tat-treated | 1 |
265 | teo₂-wo₃-zno-znx₂ | 1 |
266 | test-uptake | 1 |
267 | tetrazepinones | 1 |
268 | tpsps | 1 |
269 | transferase-dependent | 1 |
270 | triazinines | 1 |
271 | tuples | 1 |
272 | vaccinesan | 1 |
273 | vibration-rotation | 1 |
274 | vil-10 | 1 |
275 | β-naluf | 1 |
276 | β-naluf4 | 1 |
277 | ≈ζ | 1 |
1 | 'bacterial | 1 |
2 | 'biotic | 1 |
3 | 00-1 | 3 |
4 | 1,4-diaryl-5-methyl | 1 |
5 | 1/l | 5 |
6 | 1/l-induced | 5 |
7 | 10.this | 1 |
8 | 111in-ldl | 4 |
9 | 12,028 | 1 |
10 | 127-iodine | 1 |
11 | 14-3-3-beta | 6 |
12 | 16s-dna | 1 |
13 | 2,3-diaminomaleonitrile | 1 |
14 | 2,5-dihydroazepines | 1 |
15 | 2-hydroxybenzophenones | 1 |
16 | 2-salicyloylfurans | 1 |
17 | 253-kb | 3 |
18 | 2la | 19 |
19 | 3-acyl-2-substituted | 1 |
20 | 3-monochloropropan-1,2-diol | 1 |
21 | 3-or | 1 |
22 | 3-tpye | 1 |
23 | 324.5 | 1 |
24 | 36-kb | 2 |
25 | 383.1 | 1 |
26 | 4-fluoroacetophenone | 1 |
27 | 4-tpye | 1 |
28 | 50-kb | 1 |
29 | 6-capi3k | 1 |
30 | a-positive | 6 |
31 | a/pr8/34 | 1 |
32 | ab2o4 | 4 |
33 | abstraction-induced | 1 |
34 | ad169 | 2 |
35 | affective/activity | 1 |
36 | age-bsa | 1 |
37 | allele-containing | 1 |
38 | ampv-b | 1 |
39 | ancilla | 1 |
40 | antagomir | 4 |
41 | anticomplement | 1 |
42 | ar2 | 6 |
43 | aripiprazole.conclusions | 1 |
44 | autoantibody/gsk1995057 | 1 |
45 | aza-michael/aldol | 1 |
46 | azetidine | 4 |
47 | bare-silica | 1 |
48 | bc-6/85 | 1 |
49 | benzazepines | 1 |
50 | biointrafix | 1 |
51 | c1212 | 2 |
52 | cain | 3 |
53 | calcium-butyrate | 2 |
54 | calcium-calcium/calmodulin | 1 |
55 | canb2o6 | 1 |
56 | chemoprophylaxis.the | 1 |
57 | chiasma | 2 |
58 | chordal/bileaflet | 1 |
59 | citalopram+bupropion | 1 |
60 | clec2 | 3 |
61 | core-excitons | 1 |
62 | coreceptor | 32 |
63 | cotranslationally | 1 |
64 | cover-slips | 2 |
65 | cre-recombinase | 6 |
66 | cs-us | 7 |
67 | ctca/cmr | 7 |
68 | cyclopentane-fused | 1 |
69 | cyclopentenones | 1 |
70 | cyclopropyl-4,5-dihydropyridazin-3-one | 1 |
71 | deazaflavin-dependent | 1 |
72 | dermatol. | 3 |
73 | diazatricyclic | 1 |
74 | disclosure.of | 1 |
75 | dna-cp | 1 |
76 | dnaaemia | 5 |
77 | dnaemia | 20 |
78 | dnak2 | 9 |
79 | dscam1 | 6 |
80 | dual-anchor-against-an-anchor | 1 |
81 | e-mia | 4 |
82 | ebv-dna | 21 |
83 | echo-angio | 1 |
84 | eif3c | 4 |
85 | electrostatic-fluid-thermal | 1 |
86 | endodomain | 6 |
87 | envelop | 4 |
88 | eversion/ | 1 |
89 | exonucleolytic | 7 |
90 | eyyto | 5 |
91 | f-mediated | 2 |
92 | factor-κb-inhibiting | 1 |
93 | factor3 | 1 |
94 | factor4 | 1 |
95 | fano | 1 |
96 | fd-mapped | 1 |
97 | feedforward-induced | 1 |
98 | finite-fields/finite-differences | 1 |
99 | fissioning | 1 |
100 | fluid-attenuated | 41 |
101 | fluid-flow | 1 |
102 | g-band | 2 |
103 | gag | 247 |
104 | gag-reactive | 1 |
105 | gag/pol | 3 |
106 | gag/pol/nef | 9 |
107 | gamma0 | 1 |
108 | gd-specific | 1 |
109 | gdiα | 2 |
110 | genotype-iii | 2 |
111 | ghrd3/d3 | 3 |
112 | gi* | 1 |
113 | h-d | 8 |
114 | h360 | 1 |
115 | hemichromes | 1 |
116 | heterogroups | 1 |
117 | hexamethyl-propylene-amine-oxime | 1 |
118 | hiv-luciferase | 1 |
119 | hram-induced | 1 |
120 | hsp16.3 | 18 |
121 | hsp70-dnaj | 1 |
122 | hsp70-stimulated | 1 |
123 | hydrindanone | 1 |
124 | igg/igm | 2 |
125 | igm-ve | 1 |
126 | ikdc2000 | 2 |
127 | im+lh | 4 |
128 | imp-3-hnrnpm | 1 |
129 | incubation-quantitative | 1 |
130 | infection-delivery | 1 |
131 | infection-enhanced | 4 |
132 | infection/disease | 7 |
133 | infection/reactivation | 1 |
134 | ires-mediated | 2 |
135 | lanbo4 | 1 |
136 | liluf₄ | 1 |
137 | lipoprotein-mimetic | 1 |
138 | lithia | 1 |
139 | liver-transcription-factor | 1 |
140 | ljs09 | 8 |
141 | load=50 | 1 |
142 | ltr-luciferase | 2 |
143 | lx4-type | 1 |
144 | matrix-intermediate | 2 |
145 | medication.three | 1 |
146 | mir400 | 5 |
147 | mirna-expression | 1 |
148 | mixt | 3 |
149 | mode-1 | 1 |
150 | morpholino | 29 |
151 | mtdna-specific | 1 |
152 | mucin-related | 1 |
153 | mygdfx | 1 |
154 | n-ntd | 4 |
155 | n-ntds | 2 |
156 | nadh-linked | 2 |
157 | ncp7-zn | 1 |
158 | nf-at | 4 |
159 | nf449 | 4 |
160 | ngaan | 10 |
161 | nl4-3 | 3 |
162 | nomarski | 1 |
163 | non-crystallographic | 2 |
164 | ns2b/ns3 | 1 |
165 | ns5b | 67 |
166 | nsp2 | 2 |
167 | nucleoprotein | 27 |
168 | ny99 | 4 |
169 | o-antigen | 33 |
170 | o-down | 2 |
171 | o-glycopeptide | 3 |
172 | ofmost | 1 |
173 | oligonucleotide | 251 |
174 | oncotropism | 1 |
175 | orf1b | 5 |
176 | orf2 | 24 |
177 | ori-rep | 3 |
178 | p24-antigen | 6 |
179 | p24-like | 2 |
180 | p24gag | 1 |
181 | p33 | 6 |
182 | p450-mediated | 7 |
183 | p4502d6 | 1 |
184 | pamps-induced | 2 |
185 | pamps-mediated | 1 |
186 | paracentric | 1 |
187 | partonic | 1 |
188 | patient-matched | 3 |
189 | pause-dependent | 4 |
190 | pcv2-derived | 2 |
191 | peptides/hsp | 1 |
192 | perv | 5 |
193 | phase-sensitive | 8 |
194 | phosphorothioate | 25 |
195 | physical-biological | 2 |
196 | plasma/ms | 1 |
197 | pmma/nayf | 1 |
198 | pol-rt | 1 |
199 | poly-adp-ribose | 8 |
200 | polypeptide-associated | 2 |
201 | polyuronides | 1 |
202 | pp65 | 11 |
203 | pp67 | 4 |
204 | premembrane | 1 |
205 | promoter-regulated | 2 |
206 | proserotonergic | 1 |
207 | prot-rt | 1 |
208 | pseudo-particles | 2 |
209 | pseudo-substrate | 1 |
210 | pur46 | 2 |
211 | ra2cp248/404/1030deltash | 2 |
212 | rabeprazole/tinidazole/minocycline/bismuth | 1 |
213 | recombinase | 17 |
214 | replicase | 27 |
215 | retinitis-specific | 1 |
216 | retinits | 1 |
217 | retroactive | 11 |
218 | ribonuclear | 2 |
219 | ribose | 55 |
220 | ribosyl | 2 |
221 | rna | 5,144 |
222 | rna,10,000 | 1 |
223 | rna- | 4 |
224 | rna-as | 1 |
225 | rna-expressing | 1 |
226 | rna-mediated | 28 |
227 | rna-negative | 1 |
228 | rna-vl | 4 |
229 | rna/ml | 5 |
230 | rna1 | 13 |
231 | rna311 | 3 |
232 | rna≤600,000 | 1 |
233 | rna≥1,000 | 1 |
234 | rna≥100,000 | 1 |
235 | rna≥5 | 2 |
236 | robot-applied | 1 |
237 | rpl22 | 2 |
238 | sgfp | 3 |
239 | short-tau | 2 |
240 | silvernanoparticles | 1 |
241 | single-side | 1 |
242 | sipped | 2 |
243 | site-volume | 2 |
244 | speckle-type | 1 |
245 | sral2b2o7 | 2 |
246 | stockingette | 3 |
247 | sub-genomic | 2 |
248 | subtype-a | 1 |
249 | sumo-2/3 | 32 |
250 | tat-treated | 1 |
251 | teo₂-wo₃-zno-znx₂ | 1 |
252 | test-uptake | 1 |
253 | tetrazepinones | 1 |
254 | thiazole-2-carbonitriles | 2 |
255 | thiohemiacetal | 5 |
256 | tpsps | 1 |
257 | transferase-dependent | 1 |
258 | triazinines | 1 |
259 | trpm5-gfp | 3 |
260 | tuples | 1 |
261 | tw-i | 2 |
262 | ul23 | 4 |
263 | us1 | 11 |
264 | us28 | 6 |
265 | vaccinesan | 1 |
266 | vflip | 4 |
267 | vibration-rotation | 1 |
268 | vil-10 | 1 |
269 | virion-associated | 3 |
270 | vpu | 4 |
271 | wt-11 | 2 |
272 | wt-7 | 2 |
273 | zd7155 | 2 |
274 | zk60 | 7 |
275 | β-naluf | 1 |
276 | β-naluf4 | 1 |
277 | ≈ζ | 1 |
1 | gi* | 1 |
2 | rna- | 4 |
3 | dermatol. | 3 |
4 | eversion/ | 1 |
5 | rna≥100,000 | 1 |
6 | rna≤600,000 | 1 |
7 | rna,10,000 | 1 |
8 | rna≥1,000 | 1 |
9 | ikdc2000 | 2 |
10 | mir400 | 5 |
11 | vil-10 | 1 |
12 | load=50 | 1 |
13 | h360 | 1 |
14 | zk60 | 7 |
15 | gamma0 | 1 |
16 | 00-1 | 3 |
17 | mode-1 | 1 |
18 | 383.1 | 1 |
19 | wt-11 | 2 |
20 | rna311 | 3 |
21 | rna1 | 13 |
22 | dscam1 | 6 |
23 | us1 | 11 |
24 | c1212 | 2 |
25 | rpl22 | 2 |
26 | clec2 | 3 |
27 | orf2 | 24 |
28 | dnak2 | 9 |
29 | nsp2 | 2 |
30 | ar2 | 6 |
31 | nl4-3 | 3 |
32 | hsp16.3 | 18 |
33 | sumo-2/3 | 32 |
34 | ul23 | 4 |
35 | p33 | 6 |
36 | ghrd3/d3 | 3 |
37 | factor3 | 1 |
38 | ns2b/ns3 | 1 |
39 | a/pr8/34 | 1 |
40 | β-naluf4 | 1 |
41 | ab2o4 | 4 |
42 | lanbo4 | 1 |
43 | factor4 | 1 |
44 | 324.5 | 1 |
45 | zd7155 | 2 |
46 | pp65 | 11 |
47 | bc-6/85 | 1 |
48 | rna≥5 | 2 |
49 | pur46 | 2 |
50 | p4502d6 | 1 |
51 | canb2o6 | 1 |
52 | wt-7 | 2 |
53 | autoantibody/gsk1995057 | 1 |
54 | pp67 | 4 |
55 | sral2b2o7 | 2 |
56 | 12,028 | 1 |
57 | us28 | 6 |
58 | ljs09 | 8 |
59 | nf449 | 4 |
60 | ad169 | 2 |
61 | ny99 | 4 |
62 | subtype-a | 1 |
63 | bare-silica | 1 |
64 | lithia | 1 |
65 | e-mia | 4 |
66 | dnaaemia | 5 |
67 | dnaemia | 20 |
68 | 2la | 19 |
69 | ancilla | 1 |
70 | chiasma | 2 |
71 | 16s-dna | 1 |
72 | ebv-dna | 21 |
73 | rna | 5,144 |
74 | age-bsa | 1 |
75 | 14-3-3-beta | 6 |
76 | ampv-b | 1 |
77 | orf1b | 5 |
78 | ns5b | 67 |
79 | 50-kb | 1 |
80 | 253-kb | 3 |
81 | 36-kb | 2 |
82 | eif3c | 4 |
83 | mtdna-specific | 1 |
84 | gd-specific | 1 |
85 | retinitis-specific | 1 |
86 | proserotonergic | 1 |
87 | non-crystallographic | 2 |
88 | diazatricyclic | 1 |
89 | sub-genomic | 2 |
90 | partonic | 1 |
91 | paracentric | 1 |
92 | lipoprotein-mimetic | 1 |
93 | 'biotic | 1 |
94 | exonucleolytic | 7 |
95 | h-d | 8 |
96 | infection-enhanced | 4 |
97 | feedforward-induced | 1 |
98 | 1/l-induced | 5 |
99 | hram-induced | 1 |
100 | abstraction-induced | 1 |
101 | pamps-induced | 2 |
102 | patient-matched | 3 |
103 | robot-applied | 1 |
104 | nadh-linked | 2 |
105 | fd-mapped | 1 |
106 | sipped | 2 |
107 | cyclopentane-fused | 1 |
108 | tat-treated | 1 |
109 | polypeptide-associated | 2 |
110 | virion-associated | 3 |
111 | p450-mediated | 7 |
112 | rna-mediated | 28 |
113 | f-mediated | 2 |
114 | ires-mediated | 2 |
115 | pamps-mediated | 1 |
116 | mucin-related | 1 |
117 | promoter-regulated | 2 |
118 | hsp70-stimulated | 1 |
119 | fluid-attenuated | 41 |
120 | 3-acyl-2-substituted | 1 |
121 | pcv2-derived | 2 |
122 | g-band | 2 |
123 | n-ntd | 4 |
124 | single-side | 1 |
125 | oligonucleotide | 251 |
126 | o-glycopeptide | 3 |
127 | medication.three | 1 |
128 | chemoprophylaxis.the | 1 |
129 | test-uptake | 1 |
130 | p24-like | 2 |
131 | 2,3-diaminomaleonitrile | 1 |
132 | hexamethyl-propylene-amine-oxime | 1 |
133 | site-volume | 2 |
134 | premembrane | 1 |
135 | azetidine | 4 |
136 | 127-iodine | 1 |
137 | cyclopropyl-4,5-dihydropyridazin-3-one | 1 |
138 | hydrindanone | 1 |
139 | 4-fluoroacetophenone | 1 |
140 | lx4-type | 1 |
141 | speckle-type | 1 |
142 | replicase | 27 |
143 | infection/disease | 7 |
144 | recombinase | 17 |
145 | cre-recombinase | 6 |
146 | ltr-luciferase | 2 |
147 | hiv-luciferase | 1 |
148 | ribose | 55 |
149 | poly-adp-ribose | 8 |
150 | matrix-intermediate | 2 |
151 | phosphorothioate | 25 |
152 | pseudo-substrate | 1 |
153 | calcium-butyrate | 2 |
154 | stockingette | 3 |
155 | igm-ve | 1 |
156 | rna-negative | 1 |
157 | incubation-quantitative | 1 |
158 | gag-reactive | 1 |
159 | retroactive | 11 |
160 | phase-sensitive | 8 |
161 | a-positive | 6 |
162 | 3-tpye | 1 |
163 | 4-tpye | 1 |
164 | gag/pol/nef | 9 |
165 | disclosure.of | 1 |
166 | β-naluf | 1 |
167 | pmma/nayf | 1 |
168 | gag | 247 |
169 | p24gag | 1 |
170 | allele-containing | 1 |
171 | fissioning | 1 |
172 | rna-expressing | 1 |
173 | factor-κb-inhibiting | 1 |
174 | im+lh | 4 |
175 | ra2cp248/404/1030deltash | 2 |
176 | rabeprazole/tinidazole/minocycline/bismuth | 1 |
177 | tw-i | 2 |
178 | genotype-iii | 2 |
179 | nomarski | 1 |
180 | hsp70-dnaj | 1 |
181 | 6-capi3k | 1 |
182 | 1/l | 5 |
183 | physical-biological | 2 |
184 | 'bacterial | 1 |
185 | electrostatic-fluid-thermal | 1 |
186 | thiohemiacetal | 5 |
187 | 111in-ldl | 4 |
188 | rna/ml | 5 |
189 | aza-michael/aldol | 1 |
190 | 3-monochloropropan-1,2-diol | 1 |
191 | gag/pol | 3 |
192 | rna-vl | 4 |
193 | 1,4-diaryl-5-methyl | 1 |
194 | ribosyl | 2 |
195 | igg/igm | 2 |
196 | imp-3-hnrnpm | 1 |
197 | oncotropism | 1 |
198 | ngaan | 10 |
199 | vaccinesan | 1 |
200 | p24-antigen | 6 |
201 | o-antigen | 33 |
202 | cain | 3 |
203 | endodomain | 6 |
204 | nucleoprotein | 27 |
205 | calcium-calcium/calmodulin | 1 |
206 | citalopram+bupropion | 1 |
207 | mirna-expression | 1 |
208 | vibration-rotation | 1 |
209 | infection/reactivation | 1 |
210 | o-down | 2 |
211 | ncp7-zn | 1 |
212 | echo-angio | 1 |
213 | fano | 1 |
214 | morpholino | 29 |
215 | eyyto | 5 |
216 | dna-cp | 1 |
217 | ori-rep | 3 |
218 | trpm5-gfp | 3 |
219 | sgfp | 3 |
220 | vflip | 4 |
221 | envelop | 4 |
222 | peptides/hsp | 1 |
223 | ribonuclear | 2 |
224 | antagomir | 4 |
225 | ctca/cmr | 7 |
226 | 3-or | 1 |
227 | dual-anchor-against-an-anchor | 1 |
228 | liver-transcription-factor | 1 |
229 | coreceptor | 32 |
230 | rna-as | 1 |
231 | n-ntds | 2 |
232 | finite-fields/finite-differences | 1 |
233 | polyuronides | 1 |
234 | pseudo-particles | 2 |
235 | silvernanoparticles | 1 |
236 | thiazole-2-carbonitriles | 2 |
237 | tuples | 1 |
238 | hemichromes | 1 |
239 | triazinines | 1 |
240 | 2,5-dihydroazepines | 1 |
241 | benzazepines | 1 |
242 | 2-hydroxybenzophenones | 1 |
243 | cyclopentenones | 1 |
244 | tetrazepinones | 1 |
245 | 10.this | 1 |
246 | plasma/ms | 1 |
247 | 2-salicyloylfurans | 1 |
248 | aripiprazole.conclusions | 1 |
249 | core-excitons | 1 |
250 | cover-slips | 2 |
251 | tpsps | 1 |
252 | heterogroups | 1 |
253 | retinits | 1 |
254 | cs-us | 7 |
255 | nf-at | 4 |
256 | chordal/bileaflet | 1 |
257 | transferase-dependent | 1 |
258 | pause-dependent | 4 |
259 | deazaflavin-dependent | 1 |
260 | anticomplement | 1 |
261 | pol-rt | 1 |
262 | prot-rt | 1 |
263 | ofmost | 1 |
264 | mixt | 3 |
265 | short-tau | 2 |
266 | vpu | 4 |
267 | perv | 5 |
268 | fluid-flow | 1 |
269 | mygdfx | 1 |
270 | biointrafix | 1 |
271 | cotranslationally | 1 |
272 | infection-delivery | 1 |
273 | affective/activity | 1 |
274 | teo₂-wo₃-zno-znx₂ | 1 |
275 | liluf₄ | 1 |
276 | gdiα | 2 |
277 | ≈ζ | 1 |